Quipt Enters Four New States With Closings of Strategic Acquisitions
National Expansion Continues With Entrance Into California, Missouri, Arkansas and Mississippi; $5.5 Million in Annualized Revenues, 10% Adjusted EBITDA Margin...
Month: July 2021
Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BOULDER, Colo., July 14, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (“the “Company” or “Viridian”), a biopharmaceutical company...
Teladoc Health and Microsoft Collaborate to Create a Unified Practice Experience for Clinicians
Collaboration combines Teladoc Health’s Solo platform and Microsoft Teams to integrate clinical and administrative medical office operationsPURCHASE, NY, July 14,...
Syneos Health Names Michael Brooks Chief Development Officer
Newly Created Role Demonstrates Company’s Commitment to Growth and Innovation as Industry Leader in Biopharmaceutical Product DevelopmentMORRISVILLE, N.C., July 14,...
Inovalon Announces Second Quarter 2021 Earnings Conference Call
BOWIE, Md., July 14, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare,...
Vera Therapeutics Appoints Sean Grant as Chief Financial Officer
Healthcare and financial services industry veteran brings nearly 15 years of multi-disciplinary financial experience and proven track record in strategic...
BeyondSpring Strengthens Board with the Addition of Ex-Immunomedics and Constellation Commercial Head Brendan Delaney
NEW YORK, July 14, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused...
Ian Burnstein Joins Wesana Health Advisory Board
TORONTO and CHICAGO, July 14, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an...
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update
Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA...
Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19
CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel...
VitalHub Corp. Announces Multi Year Licensing Agreement With University Hospitals Dorset NHS Foundation Trust to Support New NHS Initiative
TORONTO, July 14, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the...
BriaCell Phase I/IIa Clinical Trial Combination Study in Advanced Breast Cancer Patients Open for Enrollment
NEW YORK and VANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell”...
Axogen, Inc. to Report Second Quarter Financial Results and Host Conference Call on August 4, 2021
ALACHUA, Fla. and TAMPA, Fla., July 14, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing...
Arch Scientists Awarded CIHR Grant to Study LSALT for the Prevention of Chronic Disease
TORONTO, July 14, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
MediPharm Labs Achieves Major Pharmaceutical Manufacturing Milestone: Receives Canadian GMP Pharmaceutical Drug Establishment Licence
Health Canada Drug Establishment Licence allows MediPharm Labs to conduct pharmaceutical manufacturing and sale of Active Pharmaceutical Ingredients and Pharmaceutical...
SI-BONE, Inc. Announces Centene Establishes Positive Coverage for MIS SI Joint Fusion including the Triangular iFuse Implant System
New positive coverage policy provides access to iFuse as an important treatment option for patients with chronic sacroiliac joint pain...
FDA Grants Alkeus Pharmaceuticals Breakthrough Therapy Designation for ALK-001 (C20-D3-vitamin A) for the Treatment of Stargardt Disease
Only drug to receive Breakthrough Therapy Designation for Stargardt DiseaseAlkeus Pharmaceuticals to discuss next steps toward filing an NDA with...
XORTX Therapeutics Strengthens Executive Team
Mr. Amar Keshri joins XORTX as Chief Financial OfficerCALGARY, Alberta, July 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX"...
Nkarta Establishes New Combined NK Cell Therapy Manufacturing Facility / Company Headquarters
88,000 square foot facility in South San Francisco will support scaled manufacturing of Nkarta’s engineered NK cell therapy candidates, and...
Skylight Health Acquires ACO Partners and Enters Value-Based Contracting for Traditional Medicare Patients
TORONTO, July 14, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ: SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a...